Oxford BioMedica shares up, in talks to buy ABL Europe but loss widens
(Alliance News) - Oxford BioMedica PLC on Wednesday said loss widened in the first half of 2023 as revenue fell, while it noted being in exclusive talks to buy ABL Europe from Institut Merieux SA for EUR15 million. Read More